Dr. Melissa Hodeib, DO

  • Vannuys, CA
  • Gynecologic oncologist
NPI1043581994PAC ID4486967379
Medicare patients, 2024
22
Part D claims, 2024
334
Publications
1
Hospital affiliations
3
Industry payments
$19,225
Practice address
6850 N Sepulveda Blvd, Vannuys, CA 91405
Practice phone
Call (213) 977-1214
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Los Angeles Cancer Network

Vannuys, California

See all 8 affiliations

Find Dr. Hodeib's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Melissa Hodeib is a gynecologic oncologist in Vannuys, California

Dr. Hodeib practices at Los Angeles Cancer Network in Vannuys, California.

Dr. Hodeib's NPI, 1043581994, was assigned on January 24, 2012. Dr. Hodeib graduated from WesternU College of Osteopathic Medicine of the Pacific in 2010. Dr. Hodeib holds California license 20A11932.

NPI and contact details
Medicare PAC ID
4486967379
NPI enumeration date
January 24, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(213) 977-1214
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
42
Medical school graduation
2010

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Melissa Hodeib practices at Los Angeles Cancer Network in Vannuys, California

Dr. Hodeib's primary practice is Los Angeles Cancer Network, at 6850 N Sepulveda Blvd, Vannuys, CA 91405 in Los Angeles County. The practice phone is (213) 977-1214.

  • Los Angeles Cancer Network
    6850 N Sepulveda Blvd, Vannuys, CA 91405 · Los Angeles CountyPhone(213) 977-1214

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Melissa Hodeib is affiliated with 5 sites of care and 3 medical groups

Dr. Hodeib's primary practice is Los Angeles Cancer Network in Vannuys, California. Dr. Hodeib is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Hodeib to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

See all 8 affiliations for Dr. Hodeib

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Melissa Hodeib's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hodeib practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Los Angeles Cancer NetworkAvailable with a free account
+4 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Hodeib practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Melissa Hodeib is one of 178 gynecologic oncologists in California

Gynecologic oncology is Dr. Hodeib's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Hodeib is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Hodeib is licensed in California.

Specialties and state licenses

  • Gynecologic oncology, CaliforniaPrimaryLicense 20A11932 · 2011 to 2027 · taxonomy 207VX0201X

Gynecologic oncologists near Dr. Hodeib

Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Melissa Hodeib treated 22 Medicare patients in 2024, average age 75

CMS counts 22 Medicare patients who saw Dr. Hodeib in 2024. 75% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hodeib's median patient age at 55, with 99% women.

Medicare patients, 202422
Average age75
Average risk score1.04

Chronic conditions among Dr. Hodeib's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol64%
  3. Arthritis59%

Share of Medicare patients with each condition. A patient can have several.

Dr. Hodeib's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 55

Patient panel by sex, all payers

  • Women99%
  • Men1%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Melissa Hodeib wrote 334 Medicare Part D claims in 2024

In 2024, Dr. Hodeib wrote 334 Medicare Part D claims for 82 patients. 84% of them were for generic drugs. CMS names the drug for 206 of them, across 8 drugs with 11 or more claims each, at $333,535 in total drug cost. In 2023, CMS named 266 claims across 11 drugs.

Part D claims, 2024334
Drugs named by CMS8
Total drug cost$333,535
Part D patients82

Dr. Hodeib's Part D claims by kind of drug, 2024

  • Generic279 claims84%
  • Brand-name and other55 claims16%

Dr. Hodeib's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Hodeib's Part D claims, 2024

  • Opioids11%38 of 334 claims
  • Antibiotics4%14 of 334 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2662024: 20623%

Drugs named by CMS: 8 in 2024, 11 in 2023.

See all prescribing by Dr. Hodeib

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Melissa Hodeib offers telehealth to Medicare patients

Dr. Hodeib accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hodeib as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find gynecologic oncologists like Dr. Hodeib by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Melissa Hodeib has 1 publication on record

Dmand AI links 1 paper to Dr. Hodeib in 2015. Dr. Hodeib's most frequent co-authors are Tasha R. Serna-Gallegos, MD and Krishnansu Sujata Tewari, MD.

Papers1

Dr. Hodeib's most frequent co-authors

Recent publications by Dr. Hodeib

See all 1 publications and co-authors

See who Dr. Hodeib researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hodeib works with, so you can find a warm path to the right gynecologic oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Melissa Hodeib received $19,225 in industry payments from 2016 to 2025

CMS Open Payments shows 29 general payments to Dr. Hodeib from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Pfizer Inc. paid the most, $11,398.

General payments to Dr. Hodeib by program year, 2016 to 2025

General payments to Dr. Hodeib by kind, 2016 to 2025

$19.2Kin total
  • Consulting fees$16,37585%
  • Travel and lodging$1,86910%
  • Food and beverage$9815%

Companies that paid Dr. Hodeib the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Hodeib

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Melissa Hodeib graduated from WesternU College of Osteopathic Medicine of the Pacific

Dr. Hodeib graduated from WesternU College of Osteopathic Medicine of the Pacific in 2010. Dr. Hodeib is a member of AOA.

  1. Medical schoolWesternU College of Osteopathic Medicine of the Pacific
  2. Board certified in gynecologic oncologyAmerican Board of Obstetrics and Gynecology
  3. Board certified in obstetrics & gynecologyAmerican Board of Obstetrics and Gynecology

Source: Dmand AI Professional Profile Data

Dr. Melissa Hodeib accepts plans from 2 insurance carriers

Dr. Hodeib is in network with 2 carriers, including Aetna and LA Care. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.

  • Aetna
  • LA Care

Plan types Dr. Hodeib accepts, by number of carriers

  1. HMO2
  2. EPO1
  3. Medicare1
  4. POS1
  5. PPO1

Source: Dmand AI Insurance Network Data

Sources for Dr. Melissa Hodeib's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Melissa Hodeib

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Melissa Hodeib's NPI number?

Dr. Melissa Hodeib's NPI number is 1043581994. It was assigned on January 24, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. Melissa Hodeib?

Dr. Melissa Hodeib is a gynecologic oncologist in Vannuys, California. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).

Where does Dr. Melissa Hodeib practice?

Dr. Hodeib practices at 6850 N Sepulveda Blvd, Vannuys, CA 91405. Dr. Hodeib's primary practice is Los Angeles Cancer Network in Vannuys, California. Dmand AI also links Dr. Hodeib to 2 hospitals, 2 medical groups and 1 group practice or clinic.

What is Dr. Melissa Hodeib's office phone number?

The practice phone on file for Dr. Hodeib is (213) 977-1214.

What is Dr. Melissa Hodeib's medical license number?

Dr. Hodeib holds California license 20A11932.

Which hospitals is Dr. Melissa Hodeib affiliated with?

Dr. Hodeib is affiliated with Ronald Reagan UCLA Medical Center. Dmand AI links Dr. Hodeib to 2 more hospitals.

What medical group is Dr. Melissa Hodeib part of?

Dr. Hodeib is linked to Southern California Permanente Medical Group. Dmand AI links Dr. Hodeib to 2 more medical groups.

Does Dr. Melissa Hodeib accept Medicare?

Yes. CMS lists Dr. Hodeib as accepting Medicare assignment.

Does Dr. Melissa Hodeib offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Hodeib as offering telehealth services.

How many Medicare patients does Dr. Melissa Hodeib see?

CMS counts 22 Medicare patients who saw Dr. Hodeib in 2024, with an average age of 75.

Show 8 more questionsShow fewer questions

Is Dr. Melissa Hodeib board certified?

Yes. Dr. Hodeib is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology.

Where did Dr. Melissa Hodeib go to medical school?

Dr. Hodeib graduated from WesternU College of Osteopathic Medicine of the Pacific in 2010.

What drugs does Dr. Melissa Hodeib prescribe most?

In 2024 Medicare Part D data, Dr. Hodeib's most prescribed drugs by claims were Anastrozole, Ondansetron HCl and Tramadol HCl.

Has Dr. Melissa Hodeib received payments from drug or device companies?

CMS Open Payments shows $19,225 in general payments to Dr. Hodeib from 11 companies from 2016 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Melissa Hodeib been practicing?

Dr. Hodeib graduated from medical school in 2010, 16 years ago.

Does Dr. Melissa Hodeib do research?

Dmand AI links 1 publication to Dr. Hodeib.

Who does Dr. Melissa Hodeib publish with?

Dr. Hodeib's most frequent co-authors are Tasha R. Serna-Gallegos, MD (1 shared paper) and Krishnansu Sujata Tewari, MD (1 shared paper).

What insurance does Dr. Melissa Hodeib accept?

Dr. Hodeib is in network with 2 carriers, including Aetna and LA Care. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.

Selling to gynecologic oncology practices?

See gynecologic oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)